These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 15882978)

  • 1. Caspase recruitment domain of procaspase-2 could be a target for SUMO-1 modification through Ubc9.
    Shirakura H; Hayashi N; Ogino S; Tsuruma K; Uehara T; Nomura Y
    Biochem Biophys Res Commun; 2005 Jun; 331(4):1007-15. PubMed ID: 15882978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between SUMO-1 modification of caspase-7 and its nuclear localization in human neuronal cells.
    Hayashi N; Shirakura H; Uehara T; Nomura Y
    Neurosci Lett; 2006 Apr 10-17; 397(1-2):5-9. PubMed ID: 16378684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification and activity assays for Ubc9, the ubiquitin-conjugating enzyme for the small ubiquitin-like modifier SUMO.
    Yunus AA; Lima CD
    Methods Enzymol; 2005; 398():74-87. PubMed ID: 16275321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The type 2 dengue virus envelope protein interacts with small ubiquitin-like modifier-1 (SUMO-1) conjugating enzyme 9 (Ubc9).
    Chiu MW; Shih HM; Yang TH; Yang YL
    J Biomed Sci; 2007 May; 14(3):429-44. PubMed ID: 17265167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of an N-terminal site of Ubc9 in SUMO-1, -2, and -3 binding and conjugation.
    Tatham MH; Kim S; Yu B; Jaffray E; Song J; Zheng J; Rodriguez MS; Hay RT; Chen Y
    Biochemistry; 2003 Aug; 42(33):9959-69. PubMed ID: 12924945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A non-covalent interaction between small ubiquitin-like modifier-1 and Zac1 regulates Zac1 cellular functions.
    Liu ST; Chang YL; Wang WM; Chung MH; Lin WS; Chou WY; Huang SM
    Int J Biochem Cell Biol; 2012 Mar; 44(3):547-55. PubMed ID: 22227369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Kruppel zinc finger of ZNF 146 interacts with the SUMO-1 conjugating enzyme UBC9 and is sumoylated in vivo.
    Antoine K; Prosperi MT; Ferbus D; Boule C; Goubin G
    Mol Cell Biochem; 2005 Mar; 271(1-2):215-23. PubMed ID: 15881673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The UBC9 E2 SUMO conjugating enzyme binds the PR-Set7 histone methyltransferase to facilitate target gene repression.
    Spektor TM; Congdon LM; Veerappan CS; Rice JC
    PLoS One; 2011; 6(7):e22785. PubMed ID: 21829513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ubc9-mediated sumoylation leads to transcriptional repression of IRF-1.
    Kim EJ; Park JS; Um SJ
    Biochem Biophys Res Commun; 2008 Dec; 377(3):952-6. PubMed ID: 18955028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of moloney murine leukemia virus capsid with Ubc9 and PIASy mediates SUMO-1 addition required early in infection.
    Yueh A; Leung J; Bhattacharyya S; Perrone LA; de los Santos K; Pu SY; Goff SP
    J Virol; 2006 Jan; 80(1):342-52. PubMed ID: 16352559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The DNA topoisomerase I binding protein topors as a novel cellular target for SUMO-1 modification: characterization of domains necessary for subcellular localization and sumolation.
    Weger S; Hammer E; Engstler M
    Exp Cell Res; 2003 Oct; 290(1):13-27. PubMed ID: 14516784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubc9 promotes the stability of Smad4 and the nuclear accumulation of Smad1 in osteoblast-like Saos-2 cells.
    Shimada K; Suzuki N; Ono Y; Tanaka K; Maeno M; Ito K
    Bone; 2008 May; 42(5):886-93. PubMed ID: 18321803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sumoylation of internally initiated Sp3 isoforms regulates transcriptional repression via a Trichostatin A-insensitive mechanism.
    Spengler ML; Kennett SB; Moorefield KS; Simmons SO; Brattain MG; Horowitz JM
    Cell Signal; 2005 Feb; 17(2):153-66. PubMed ID: 15494207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dnmt3b, de novo DNA methyltransferase, interacts with SUMO-1 and Ubc9 through its N-terminal region and is subject to modification by SUMO-1.
    Kang ES; Park CW; Chung JH
    Biochem Biophys Res Commun; 2001 Dec; 289(4):862-8. PubMed ID: 11735126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RAP80 interacts with the SUMO-conjugating enzyme UBC9 and is a novel target for sumoylation.
    Yan J; Yang XP; Kim YS; Joo JH; Jetten AM
    Biochem Biophys Res Commun; 2007 Oct; 362(1):132-138. PubMed ID: 17698038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into E3 ligase activity revealed by a SUMO-RanGAP1-Ubc9-Nup358 complex.
    Reverter D; Lima CD
    Nature; 2005 Jun; 435(7042):687-92. PubMed ID: 15931224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BCL11A is a SUMOylated protein and recruits SUMO-conjugation enzymes in its nuclear body.
    Kuwata T; Nakamura T
    Genes Cells; 2008 Sep; 13(9):931-40. PubMed ID: 18681895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SUMO Ubc9 enzyme as a viral target.
    Varadaraj A; Mattoscio D; Chiocca S
    IUBMB Life; 2014 Jan; 66(1):27-33. PubMed ID: 24395713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional activity of megakaryoblastic leukemia 1 (MKL1) is repressed by SUMO modification.
    Nakagawa K; Kuzumaki N
    Genes Cells; 2005 Aug; 10(8):835-50. PubMed ID: 16098147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Ubc9, an E2 ligase for SUMO conjugation, with p53 is regulated by phosphorylation of p53.
    Lin JY; Ohshima T; Shimotohno K
    FEBS Lett; 2004 Aug; 573(1-3):15-8. PubMed ID: 15327968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.